Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
PUT
Biohaven
BHVN
$2.33B
| $718K | ﹤0.01% |
+30,000
| New | +$516K |
|
4227
HDFC Bank
HDB
$119B
| $717K | ﹤0.01% |
20,582
-203,382
| -91% | -$6.86M |
|
4228
PUT
Vanguard FTSE Europe ETF
VGK
$30.9B
| $716K | ﹤0.01% |
+11,600
| New | +$721K |
|
4229
Cenntro
CENN
$10.2M
| $714K | ﹤0.01% |
+4,115
| New | +$871K |
|
|
FONR
4230
DELISTED
Fonar
FONR
| $714K | ﹤0.01% |
41,745
-955
| -2% | -$15.9K |
|
4231
CALL
Viridian Therapeutics
VRDN
$2.61B
| $714K | ﹤0.01% |
+30,000
| New | +$769K |
|
|
OMIC
4232
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $714K | ﹤0.01% |
+28,657
| New | +$840K |
|
|
NFGC
4233
New Found Gold
NFGC
$734M
| $713K | ﹤0.01% |
143,618
+70,807
| +97% | +$338K |
|
4234
Cousins Properties
CUZ
$4.85B
| $711K | ﹤0.01% |
+31,190
| New | +$652K |
|
4235
CALL
BioCryst Pharmaceuticals
BCRX
$2.51B
| $710K | ﹤0.01% |
100,900
-138,400
| -58% | -$1.11M |
|
|
STKL
4236
DELISTED
SunOpta
STKL
| $710K | ﹤0.01% |
106,165
-719,422
| -87% | -$5.41M |
|
4237
iShares Russell 3000 ETF
IWV
$20.3B
| $710K | ﹤0.01% |
+2,789
| New | +$671K |
|
4238
Tucows
TCX
$113M
| $709K | ﹤0.01% |
25,567
+11,670
| +84% | +$301K |
|
4239
Unitil
UTL
$968M
| $708K | ﹤0.01% |
13,963
-50,392
| -78% | -$2.8M |
|
|
PCGU
4240
DELISTED
PG&E Corporation
PCGU
| $705K | ﹤0.01% |
+4,701
| New | +$693K |
|
4241
Celldex Therapeutics
CLDX
$3.07B
| $704K | ﹤0.01% |
+20,740
| New | +$699K |
|
|
HBI
4242
CALL
DELISTED
Hanesbrands
HBI
| $701K | ﹤0.01% |
154,300
+4,100
| +3% | +$18.7K |
|
4243
PUT
Viking Therapeutics
VKTX
$3.75B
| $697K | ﹤0.01% |
43,000
-188,000
| -81% | -$3.94M |
|
4244
CALL
Prothena Corp
PRTA
$479M
| $696K | ﹤0.01% |
+10,200
| New | +$658K |
|
|
LSEA
4245
DELISTED
Landsea Homes
LSEA
| $695K | ﹤0.01% |
74,393
+4,934
| +7% | +$34.5K |
|
4246
Mistras Group
MG
$589M
| $693K | ﹤0.01% |
89,825
-260,325
| -74% | -$1.94M |
|
4247
CALL
Ultragenyx Pharmaceutical
RARE
$2.52B
| $692K | ﹤0.01% |
+15,000
| New | +$696K |
|
4248
PUT
Mercury Systems
MRCY
$5.32B
| $692K | ﹤0.01% |
+20,000
| New | +$854K |
|
4249
Prudential
PUK
$34.3B
| $691K | ﹤0.01% |
24,413
-14,045
| -37% | -$402K |
|
4250
CALL
State Street Communication Services Select Sector SPDR ETF
XLC
$22.8B
| $690K | ﹤0.01% |
10,600
-92,000
| -90% | -$5.6M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.